{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:25:08Z","timestamp":1794219908649,"version":"4.8.0"},"reference-count":29,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Rathke\u2019s cleft cysts (RCCs) and craniopharyngiomas (CPs) are lesions of the sellar region, both originating from remnants of Rathke\u2019s diverticulum. The presence of squamous metaplasia (SM) within RCCs often creates histological overlaps with papillary CPs (PCPs), complicating accurate diagnosis. Given the distinct treatment and clinical outcomes associated with these lesions, precise identification is essential. BRAF V600E and CTNNB1 mutations have emerged as distinguishing genetic markers for PCP and adamantinomatous CP (ACP), respectively. This study aimed to evaluate the utility of BRAF V600E and \u03b2-catenin immunohistochemistry in differentiating RCC from CP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors retrospectively reviewed the clinical, radiological, and histopathological data of 383 RCCs diagnosed between January 2015 and May 2024 at Beijing Tiantan Hospital. BRAF V600E and CTNNB1 immunohistochemistry were performed on all cases, with BRAF results confirmed via Sanger sequencing. Clinical outcomes were evaluated during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Sixty-nine RCC cases met the inclusion criteria (61 primary and 8 recurrent). Of these, 52 cases were in intrasellar region (75.4%), with 9 cases (13.0%) in the suprasellar region and 8 cases (11.6%) involving both regions. Histologically, 39 cases (56.5%) exhibited epithelial SM. No nuclear \u03b2-catenin accumulation localization was detected. BRAF V600E expression was observed in 7 cases (10.1%), all within areas of SM, and confirmed with Sanger sequencing. These positive cases also showed elevated Ki-67 indices, with proliferative activity concentrated at the basal layer of the epithelium with SM. Based on these molecular and histological findings, the 7 BRAF V600E\u2013positive cases were reclassified as PCPs. Notably, Kaplan-Meier analysis demonstrated significantly worse progression-free survival in BRAF V600E\u2013positive cases compared to wild-type cases (p = 0.023).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>BRAF V600E and CTNNB1 mutation analysis is a valuable diagnostic tool for distinguishing RCC from CP. Given the potential for RCC to transform into PCP, the authors recommend BRAF V600E testing for all RCC cases. For BRAF V600E\u2013positive cases, close monitoring of tumor progression or adjuvant therapies is advised.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.12.jns251886","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:53:47Z","timestamp":1778291627000},"page":"693-704","source":"Crossref","is-referenced-by-count":0,"title":["Surgical implications of BRAF V600E\u2013positive Rathke\u2019s cleft cysts: prediction of early recurrence based on reclassification to papillary craniopharyngioma"],"prefix":"10.3171","volume":"145","author":[{"given":"Loke Yuan","family":"Shee","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"},{"name":"Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisu","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbai","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"Neurosurg Rev","first-page":"522","article-title":"Rathke\u2019s cleft cysts: from pathophysiology to management","volume":"47","author":"Aydin S","year":"2024","unstructured":"Aydin S, Darko K, Detchou D, Barrie U. Rathke\u2019s cleft cysts: from pathophysiology to management. Neurosurg Rev. 2024;47(1):522. doi:10.1007\/s10143-024-02742-0"},{"issue":"4","key":"b2","series-title":"Pituitary","first-page":"393","article-title":"Clinical and imaging findings for the evaluation of large Rathke\u2019s cleft cysts and cystic craniopharyngiomas","volume":"26","author":"Yang CH","year":"2023","unstructured":"Yang CH, Wu CH, Lin TM,  Clinical and imaging findings for the evaluation of large Rathke\u2019s cleft cysts and cystic craniopharyngiomas. Pituitary. 2023;26(4):393\u2013401. doi:10.1007\/s11102-023-01326-3"},{"key":"b3","series-title":"NMC Case Rep J","first-page":"191","article-title":"A case of papillary craniopharyngioma mimicking Rathke\u2019s cleft cyst","volume":"11","author":"Harada H","year":"2024","unstructured":"Harada H, Takeuchi K, Nagata Y,  A case of papillary craniopharyngioma mimicking Rathke\u2019s cleft cyst. NMC Case Rep J. 2024;11:191\u2013194. doi:10.2176\/jns-nmc.2024-0057"},{"key":"b4","series-title":"Front Oncol","first-page":"649958","article-title":"A potential concomitant sellar embryonic remnant-associated collision tumor: systematic review","volume":"11","author":"Wang M","year":"2021","unstructured":"Wang M, Fu Q, Song M,  A potential concomitant sellar embryonic remnant-associated collision tumor: systematic review. Front Oncol. 2021;11:649958. doi:10.3389\/fonc.2021.649958"},{"key":"b5","series-title":"Int J Surg Case Rep","first-page":"104","article-title":"Rathke\u2019s cleft cyst presentation mimicking craniopharyngioma: case report","volume":"68","author":"Farrash FA","year":"2020","unstructured":"Farrash FA, Hassounah M, Helmi HA, Othman E, Alotaibi NH. Rathke\u2019s cleft cyst presentation mimicking craniopharyngioma: case report. Int J Surg Case Rep. 2020;68:104\u2013106. doi:10.1016\/j.ijscr.2020.01.035"},{"issue":"6","key":"b6","series-title":"J Neurosurg","first-page":"1380","article-title":"Characteristics of Rathke\u2019s cleft cyst based on cyst location with a primary focus on recurrence after resection","volume":"122","author":"Chotai S","year":"2015","unstructured":"Chotai S, Liu Y, Pan J, Qi S. Characteristics of Rathke\u2019s cleft cyst based on cyst location with a primary focus on recurrence after resection. J Neurosurg. 2015;122(6):1380\u20131389. doi:10.3171\/2014.12.JNS14596"},{"issue":"2","key":"b7","series-title":"Rev Endocr Metab Disord","first-page":"229","article-title":"Rathke\u2019s cleft cyst: from history to molecular genetics","volume":"26","author":"Hacioglu A","year":"2025","unstructured":"Hacioglu A, Tekiner H, Altinoz MA,  Rathke\u2019s cleft cyst: from history to molecular genetics. Rev Endocr Metab Disord. 2025;26(2):229\u2013260. doi:10.1007\/s11154-025-09949-6"},{"issue":"6","key":"b8","series-title":"Acta Neuropathol","first-page":"927","article-title":"BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma","volume":"127","author":"Larkin SJ","year":"2014","unstructured":"Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol. 2014;127(6):927\u2013929. doi:10.1007\/s00401-014-1270-6"},{"key":"b9","series-title":"Front Endocrinol (Lausanne)","first-page":"1488958","article-title":"Practical application of precision oncology in adult onset craniopharyngiomas","volume":"15","author":"Biswas C","year":"2024","unstructured":"Biswas C, Mansur G, Wu KC, Prevedello DM, Ghalib L. Practical application of precision oncology in adult onset craniopharyngiomas. Front Endocrinol (Lausanne). 2024;15:1488958. doi:10.3389\/fendo.2024.1488958"},{"issue":"3","key":"b10","series-title":"Endocr Rev","first-page":"518","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps JR","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP. Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev. 2023;44(3):518\u2013538. doi:10.1210\/endrev\/bnac035"},{"issue":"8","key":"b11","series-title":"Jpn J Radiol","first-page":"808","article-title":"Imaging of pituitary tumors: an update with the 5th WHO classifications-part 2. Neoplasms other than PitNET and tumor-mimicking lesions","volume":"41","author":"Tsukamoto T","year":"2023","unstructured":"Tsukamoto T, Miki Y. Imaging of pituitary tumors: an update with the 5th WHO classifications-part 2. Neoplasms other than PitNET and tumor-mimicking lesions. Jpn J Radiol. 2023;41(8):808\u2013829. doi:10.1007\/s11604-023-01407-0"},{"issue":"2","key":"b12","series-title":"Neurol India","first-page":"403","article-title":"Rathke\u2019s cleft cyst and craniopharyngioma: a continuum of the same spectrum? Insights from an interesting case and previous literature","volume":"72","author":"Sharma R","year":"2024","unstructured":"Sharma R, Meena R, Ganeshkumar A,  Rathke\u2019s cleft cyst and craniopharyngioma: a continuum of the same spectrum? Insights from an interesting case and previous literature. Neurol India. 2024;72(2):403\u2013407. doi:10.4103\/ni.ni_1210_21"},{"issue":"6","key":"b13","series-title":"J Neurosurg","first-page":"1322","article-title":"A Rathke cleft cyst to craniopharyngioma: is there a spectrum?","volume":"112","author":"Wolfe SQ","year":"2010","unstructured":"Wolfe SQ, Heros RC. A Rathke cleft cyst to craniopharyngioma: is there a spectrum? J Neurosurg. 2010;112(6):1322\u20131323. doi:10.3171\/2009.10.JNS091265"},{"issue":"4","key":"b14","series-title":"Mod Pathol","first-page":"596","article-title":"Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia","volume":"28","author":"Jones RT","year":"2015","unstructured":"Jones RT, Abedalthagafi MS, Brahmandam M,  Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia. Mod Pathol. 2015;28(4):596\u2013606. doi:10.1038\/modpathol.2014.150"},{"issue":"3","key":"b15","series-title":"JAMA Oncol","first-page":"317","article-title":"Molecular testing for the World Health Organization classification of central nervous system tumors: a review","volume":"11","author":"Horbinski C","year":"2025","unstructured":"Horbinski C, Solomon DA, Lukas RV,  Molecular testing for the World Health Organization classification of central nervous system tumors: a review. JAMA Oncol. 2025;11(3):317\u2013328. doi:10.1001\/jamaoncol.2024.5506"},{"issue":"6","key":"b16","series-title":"Neuropathol Appl Neurobiol","first-page":"733","article-title":"BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke\u2019s cleft cysts","volume":"41","author":"Schweizer L","year":"2015","unstructured":"Schweizer L, Capper D, H\u00f6lsken A,  BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke\u2019s cleft cysts. Neuropathol Appl Neurobiol. 2015;41(6):733\u2013742. doi:10.1111\/nan.12201"},{"issue":"1","key":"b17","series-title":"Pituitary","first-page":"30","article-title":"The role of BRAF testing of Rathke\u2019s cleft cysts to identify missed papillary craniopharyngioma","volume":"28","author":"Candy NG","year":"2025","unstructured":"Candy NG, Mignone E, Quick E,  The role of BRAF testing of Rathke\u2019s cleft cysts to identify missed papillary craniopharyngioma. Pituitary. 2025;28(1):30. doi:10.1007\/s11102-025-01501-8"},{"issue":"4","key":"b18","series-title":"Endocr Pathol","first-page":"422","article-title":"Spontaneous alteration from Rathke\u2019s cleft cyst to craniopharyngioma\u2013possible involvement of transformation between these pathologies","volume":"25","author":"Ogawa Y","year":"2014","unstructured":"Ogawa Y, Watanabe M, Tominaga T. Spontaneous alteration from Rathke\u2019s cleft cyst to craniopharyngioma\u2013possible involvement of transformation between these pathologies. Endocr Pathol. 2014;25(4):422\u2013426. doi:10.1007\/s12022-014-9328-5"},{"key":"b19","series-title":"Front Genet","first-page":"49","article-title":"Rathke\u2019s cleft cyst as origin of a pediatric papillary craniopharyngioma","volume":"9","author":"Schlaffer SM","year":"2018","unstructured":"Schlaffer SM, Buchfelder M, Stoehr R, Buslei R, Holsken A. Rathke\u2019s cleft cyst as origin of a pediatric papillary craniopharyngioma. Front Genet. 2018;9:49. doi:10.3389\/fgene.2018.00049"},{"issue":"6","key":"b20","series-title":"Clin Neuropathol","first-page":"388","article-title":"V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior","volume":"33","author":"Bannykh SI","year":"2014","unstructured":"Bannykh SI, Mirocha J, Nuno M, Lopategui J, Kandala G. V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior. Clin Neuropathol. 2014;33(6):388\u2013398. doi:10.5414\/NP300753"},{"issue":"9","key":"b21","series-title":"J Clin Oncol","first-page":"1015","article-title":"BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma","volume":"33","author":"Mistry M","year":"2015","unstructured":"Mistry M, Zhukova N, Merico D,  BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol. 2015;33(9):1015\u20131022. doi:10.1200\/JCO.2014.58.3922"},{"key":"b22","series-title":"Neuro Oncol","first-page":"noaf249","article-title":"Interrogation of the cellular hierarchies reveals neoplastic evolution and therapeutic vulnerability in craniopharyngioma","author":"Zhang B","year":"2025","unstructured":"Zhang B, Zhang J, Li Z,  Interrogation of the cellular hierarchies reveals neoplastic evolution and therapeutic vulnerability in craniopharyngioma. Neuro Oncol. 2025:noaf249. doi:10.1093\/neuonc\/noaf249"},{"issue":"5","key":"b23","series-title":"J Neurosurg","first-page":"1352","article-title":"Endoscopic endonasal resection of Rathke cleft cysts: a single-institution analysis of 148 consecutive patients","volume":"141","author":"Algattas HN","year":"2024","unstructured":"Algattas HN, Gersey ZC, Fernandes Cabral D,  Endoscopic endonasal resection of Rathke cleft cysts: a single-institution analysis of 148 consecutive patients. J Neurosurg. 2024;141(5):1352\u20131362. doi:10.3171\/2024.3.JNS232740"},{"issue":"1","key":"b24","series-title":"J Neurooncol","first-page":"189","article-title":"BRAF V600E mutation is a useful marker for differentiating Rathke\u2019s cleft cyst with squamous metaplasia from papillary craniopharyngioma","volume":"123","author":"Kim JH","year":"2015","unstructured":"Kim JH, Paulus W, Heim S. BRAF V600E mutation is a useful marker for differentiating Rathke\u2019s cleft cyst with squamous metaplasia from papillary craniopharyngioma. J Neurooncol. 2015;123(1):189\u2013191. doi:10.1007\/s11060-015-1757-6"},{"issue":"6","key":"b25","series-title":"Pituitary","first-page":"905","article-title":"Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells","volume":"18","author":"Marucci G","year":"2015","unstructured":"Marucci G, de Biase D, Zoli M,  Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells. Pituitary. 2015;18(6):905\u2013911. doi:10.1007\/s11102-015-0669-y"},{"issue":"6","key":"b26","series-title":"J Clin Exp Pathol","first-page":"291","article-title":"Brafv600e and Ctnnb1 mutational study in Rathke\u2019s cleft cysts","volume":"6","author":"Antonelli M","year":"2016","unstructured":"Antonelli M, Badiali M, Moi L,  Brafv600e and Ctnnb1 mutational study in Rathke\u2019s cleft cysts. J Clin Exp Pathol. 2016;6(6):291."},{"issue":"31","key":"b27","series-title":"Oncotarget","first-page":"50564","article-title":"TREM-1 expression in craniopharyngioma and Rathke\u2019s cleft cyst: its possible implication for controversial pathology","volume":"7","author":"Liu Y","year":"2016","unstructured":"Liu Y, Wang CH, Li DL,  TREM-1 expression in craniopharyngioma and Rathke\u2019s cleft cyst: its possible implication for controversial pathology. Oncotarget. 2016;7(31):50564\u201350574. doi:10.18632\/oncotarget.10501"},{"issue":"2","key":"b28","series-title":"Acta Neurochir (Wien)","first-page":"303","article-title":"Ciliated craniopharyngioma\u2013case report and pathological study","volume":"152","author":"Okada T","year":"2010","unstructured":"Okada T, Fujitsu K, Miyahara K,  Ciliated craniopharyngioma\u2013case report and pathological study. Acta Neurochir (Wien). 2010;152(2):303\u2013307. doi:10.1007\/s00701-009-0448-5"},{"issue":"3","key":"b29","series-title":"J Neurosurg Pediatr","first-page":"250","article-title":"Craniopharyngioma arising in a Rathke\u2019s cleft cyst: case report","volume":"15","author":"Alomari AK","year":"2015","unstructured":"Alomari AK, Kelley BJ, Damisah E,  Craniopharyngioma arising in a Rathke\u2019s cleft cyst: case report. J Neurosurg Pediatr. 2015;15(3):250\u2013254. doi:10.3171\/2014.11.PEDS14370"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/145\/3\/article-p693.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/145\/3\/article-p693.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/145\/3\/article-p693.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:56:39Z","timestamp":1794218199000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/145\/3\/article-p693.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":29,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2025.12.jns251886","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}